“…[7,[75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90][91][92], Candida spp. [93][94][95], Amoeba proteus [96,97], P. falciparum [98][99][100][101], Leishmania donovani and Leishmania major [102][103][104][105][106][107], Trypanosoma [108][109][110] and helminths [111] in vitro and in vivo [2, 3, 19, 23, 26, 41, 49, 51, 53, 56, 61, 67-69, 71-74, 77, 82-89, 91, 105, 108, 109] by altering the permeability of the microbial cell membrane [2, 3, 18-20, 23, 25, 27, 30, 34, 38-40, 46, 54, 59, 60, 79, 81, 95, 101-103, 107, 112] and enhance the in vitro and in vivo activity of certain antibiotics against specific bacteria [2,18,39,128,130] to make antibiotic-resistant bacteria susceptible to the previously used antibiotics …”